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Tubular atrophy and interstitial fibrosis, important in
progression of renal diseases, including diabetic (D) and
cyclosporine-induced (CSA) nephropathy, have been
considered irreversible. Normoglycemia for 10 years
following pancreas transplantation alone (PTA) reversed D
glomerulopathy lesions. This study quantified tubular,
interstitial, and arteriolar parameters in PTA recipients.
Kidney function studies and biopsies were performed in eight
non-uremic type I D patients (pts) at 5 and 10 years after PTA.
Renal biopsies were analyzed by morphometric analysis. All
pts were normoglycemic and insulin independent and
received CSA during the study. Cortical interstitial volume
fraction was increased at 5 years (0.3170.07 vs normal
0.1570.02, Po0.01) and decreased at 10 years post-PTA
(0.2370.03, Po0.02 vs 5 years). There was a reduction in the
volume fraction of interstitial collagen and cells per cortical
tissue, measured using electron microscopy, from 5
(0.12670.061 and 0.10370.026, respectively) to 10 years
(0.07970.031, Po0.05, and 0.07470.018, Po0.05,
respectively). The volume fraction of tubules which were
atrophic (AT) was abnormal at 5 years (0.16070.090) and
decreased from 5 to 10 years (0.04470.034, Po0.02),
apparently due to AT reabsorption. The index of arteriolar
hyalinosis did not change during the study (1.3070.22 and
1.3470.33 at 5 and 10 years, respectively, nonsignificant).
This study demonstrates, for the first time in humans, that
interstitial expansion is reversible and that atrophic tubules
can be reabsorbed. In contrast, there was no improvement in
the arteriolar lesions. Whether this is due to long-term
normoglycemia, reduction of CSA dose or other mechanisms
is unclear.
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Interstitial fibrosis is considered critical to the progressive
loss of renal function in different human glomerular
diseases.1–4 An increase in the relative volume of the cortical
interstitium is highly correlated with tubular lesions,
especially tubular atrophy; thus, the term tubulo-interstitial
lesions is frequently used. The expansion of the interstitial
space in chronic renal diseases is mainly due to increased
extracellular matrix, although increased cellularity (fibro-
blasts, macrophages, and lymphocytes) may also contri-
bute.5–7 This accumulation of interstitial extracellular matrix,
termed interstitial fibrosis, has generally been considered to
be irreversible. Recent studies in experimental animals,
however, suggest that the increase in the fraction of the
cortical volume occupied by the interstitium (Vv(Int/
cortex)), consequent to short-term ureteral obstruction, can
improve upon removal of the obstruction,8 and that the rate
of this interstitial remodeling can be accelerated by
angiotensin-converting enzyme inhibitor therapy.9 In sub-
totally nephrectomized rats, high-dose angiotensin-convert-
ing enzyme inhibitor treatment induces partial reversal of
interstitial and glomerular lesions.10
Interstitial expansion in man can be influenced by
treatment. Two years of angiotensin-converting enzyme
inhibitor therapy halted the increase in Vv(Int/cortex) in
type II diabetic (D) patients (pts) with nephropathy, while
there was a further increase in this parameter in the untreated
group.11 Reversal of interstitial expansion in humans, how-
ever, has not been demonstrated; thus, as recently discussed,12
whether the results achieved in rats are applicable
to chronic kidney disease in humans is currently unknown.
We have previously reported that mesangial expansion
as well as glomerular (GBM) and tubular basement
membrane (TBM) thickening can be reversed in type I D
pts’ native kidneys following successful pancreas transplanta-
tion alone (PTA),13 demonstrating that these renal structures
can undergo substantial architectural remodeling, with net
removal of glomerular extracellular matrix material. In-
creased Vv(Int/cortex), a common finding in long-standing
diabetes,14–18 was present in all the pts in this study
before PTA.19 These pts, in addition, received cyclosporine,
which is known to cause interstitial fibrosis.20 The present
study explored whether remodeling and healing can also
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occur in the renal interstitium and tubules in these PTA
recipients.
RESULTS
Cyclosporine (CSA) dose decreased from 8.573.2 mg/kg/day
in the first year after PTA to 5.071.9 mg/kg/day at 5 years
(Po0.01) and to 3.871.5 mg/kg/day at 10 years after PTA
(Po0.05 vs 5 years). CSA blood levels decreased from
193764 mg/l in the first year to 102740 mg/l at 5 years
(Po0.005) and 71724 mg/l at 10 years after PTA (Po0.05 vs
5 years). Significant correlations were observed between CSA
daily dose and CSA blood levels (Po0.01). Also, as
previously shown, there were significant correlations between
CSA dose and blood levels in the first PTA year and the
reduction in creatinine clearance.19
Renal structure
Light microscopy. Cortical interstitial volume fraction
(Vv(Int/cortex)) was 0.3170.07 at 5 years and significantly
decreased at 10 years post-PTA (0.2370.03, Po0.02) (Figure
1a). These quantitative findings were associated with a
decrease from 5 to 10 years in the subjectively estimated
extent of interstitial periodic acid-Shiff (PAS)-positive
staining in these biopsies (Figures 2a and b). Similarly, the
fractional volume of ATs (Vv(AT/TT)) decreased from
0.16070.090 at 5 years to 0.04470.034 at 10 years
(Po0.02) (Figure 1b).
Average tubular profile areas were similar at 5 years
(13107276 mm2) and at 10 years (14307353 mm2, nonsigni-
ficant (NS)), as were average distal tubular profile areas
(597795 and 5717207 mm2 at 5 and 10 years, respectively,
NS).
Arteriolar hyalinosis score was 1.3070.23 at 5 years and
remained unchanged at 10 years (1.3470.37, NS).
The percent of sclerotic glomeruli was 29720% at 5 years
and 35717% at 10 years (NS). All biopsies contained one or
more sclerotic glomeruli. Most of the sclerotic glomeruli in
the 5- and 10-year biopsies were incompletely surrounded by
Bowman’s capsule. The percentage of the profile of sclerotic
glomeruli which was surrounded by Bowman’s capsule
decreased from 5 (60.4730.1%) to 10 years (28.3711.1%,
Po0.03). Where Bowman’s capsule was partially or com-
pletely lost from the profile, direct contact of interstitial cells
with the tuft material of sclerotic glomeruli was regularly
observed.
Two of eight biopsies at 5 years and seven of eight at
10 years (Po0.001) had one or more sclerotic glomeruli
without adjacent AT. Figure 2c illustrates this phenomenon.
Also, of note, some sclerotic glomeruli appeared to be
losing PAS-positive basement membrane material (Figure 2b
and c).
The changes in albumin excretion rate (AER) from 5 to 10
years were not significantly correlated with the changes in
Vv(Int/cortex) (r¼ 0.67, P¼ 0.07) and Vv(AT/TT) (r¼ 0.62,
P¼ 0.10) over the same time interval. Also, the changes in
AER from baseline (before-PTA) to 10 years were not
correlated with the changes in the structural parameters from
the fifth to the 10th year.
Electron microscopy. The volume fractions of the four
interstitial components, Vv(Cell/int), Vv(Col/int), Vv(Cap/
int), and Vv(Space/int), were not significantly different
between the 5 and 10 years post-PTA biopsies, although
there was a trend towards an increase in Vv(Cap/int) from the
fifth to the 10th year (P¼ 0.096; Table 1). The volume
fraction of the cellular and collagen interstitial components
per cortical tissue, in contrast, decreased from the fifth to the
10th year post-proximal tubular (PT) profile (Table 1).
DISCUSSION
This study demonstrates, for the first time in human renal
disease, that interstitial expansion is reversible and that
atrophic tubules (ATs) can be reabsorbed. We documented
architectural remodeling in glomerular and tubular extra-
cellular matrix structures in long-standing type I D pts
rendered normoglycemic for 10 years by successful PTA.13
This was not demonstrable in the 5-year biopsies.21 However,
this was documented by electron microscopic morphometric
analysis as reductions between the fifth and the 10th year
after PTA in glomerular basement membrane and TBM
thickening, and in mesangial matrix expansion, and was
manifest, by light microscopy, as reversal of D glomerular
lesions, including the disappearance of Kimmelstiel–Wilson
nodules.13
The improvement in interstitial expansion between the
fifth and 10th year following PTA may reflect similar
phenomena. This improvement apparently results from
interstitial extracellular matrix removal exceeding extracel-
lular matrix production. The reduction in interstitial
fractional volume was not associated with a statistically
significant change in interstitial composition. However,
considered in the context of cortical tissue, there was a
significant decrease in total amount of interstitial collagen
and cellular material (Table 1). This was consistent with a
subjective decrease in light microscopic interstitial PAS-
positive staining (Figures 2a and b). A less likely explanation
for the reduction in interstitial fractional volume is that renal
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Figure 1 | Cortical interstitial volume fraction (Vv(Int/cortex)) and
fractional volume of ATs (Vv(AT/TT)) at 5 and 10 years after
pancreas transplantation. Data for individual pts are connected by
lines.
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size increased between the fifth and the 10th year post-PTA.
However, normalization of blood glucose levels should lead
to a reduction in kidney size rather than an increase.22 Since
kidney size data were not available, we measured mean
proximal and distal tubular profile areas. Tubules make up
approximately 85% of cortical volume and renal hypertrophy
is regularly associated with tubular enlargement. The nearly
identical tubular profile areas at 5 and 10 post-PTA years is
strong evidence that renal hypertrophy did not occur over
that time. These findings indicate that the reduction in
interstitial fractional volume between the fifth and 10th post-
PTA year is consequent to the disappearance of interstitial
tissue, especially collagen and cellular components, both of
which have been shown to contribute to the increase in
interstitial fractional volume in D pts.23
There was also a reduction between the fifth and 10th
post-PTA year in the fractional volume of cortical AT. This
appeared, at least in part, to be due to the disappearance of
AT, as demonstrated by studying those tubular profiles
surrounding sclerotic glomeruli. This reabsorption process
probably involves additional mechanisms, likely including
the recruitment of circulating mononuclear leukocytes,5–7
resulting in complete removal of the extracellular matrix and
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Figure 2 | Photomicrographs of renal biopsy specimens obtained 5 and 10 years after PTA from the same patient (periodic acid-Schiff).
Panel a illustrates the 5-year post-PTA renal biopsy specimen. There are areas of advanced interstitial fibrosis (double arrows) and tubular
atrophy (single arrows). Note the presence of diffuse and nodular D glomerulopathy. Panel b illustrates the 10-year post-PTA biopsy specimen.
There is marked improvement in the interstitial fibrosis compared to panel a. Only a few TBM remnants of ATs remain (single arrow). There is a
globally sclerotic glomerulus surrounded by normal tubules (double arrow). The remaining glomeruli show almost complete resolution of D
glomerular changes compared to panel a. Panel c: This photomicrograph of the10-year post-PTA biopsy illustrates three glomeruli: the central
glomerulus is nearly normal; the globally sclerotic glomerulus on the left contains intensely PAS-positive staining basement membrane and
mesangial matrix materials, and is surrounded by intact Bowman’s capsule, ATs, and interstitial fibrosis. The glomerulus on the right is also
globally sclerotic, but with much less PAS positivity in the extracellular matrix staining and nearly absent Bowman’s capsule. The tubules
surrounding this pale sclerotic glomerulus are normal, but for a small TBM remnant PAS, original magnification  150.
Table 1 | Interstitial composition by electron microscopy at 5
and 10 years after pancreas transplantation
5 years post-PTA 10 years post-PTA P-value
Vv(Cell/int) 0.35570.152 0.32970.070 0.554
Vv(Cell/cortex) 0.10370.026 0.07470.02 0.046
Vv(Coll/int) 0.38470.132 0.37170.098 0.715
Vv(Coll/cortex) 0.12770.061 0.07970.032 0.049
Vv(Cap/int) 0.19970.056 0.24870.063 0.096
Vv(Cap/cortex) 0.06370.025 0.05570.012 0.376
Vv(Space/int) 0.06870.040 0.05270.027 0.453
Vv(Space/cortex) 0.02370.016 0.01370.009 0.208
Data are presented as mean7s.d.
Vv(Cell/int), Vv(Coll/int), Vv(Cap/int) and Vv(Space/int)=fractional volume of cells,
collagen, capillaries and space per interstitium.
Vv(Cell/cortex), Vv(Coll/cortex), Vv(Cap/cortex) and Vv(Space/cortex)=fractional volume
of cells, collagen, capillaries and space per cortical tissue.
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cellular components of these AT, rather than remodeling
towards normal. In contrast, when the non-atrophic
proximal tubules were studied, we observed reversal of the
thickening of TBMs.13 Much more would need to be known
about these processes before it could be understood how
these systems are regulated, whereby tubules with TBM
thickening undergo TBM remodeling while tubules with
more advanced injury, particularly those related to sclerotic
glomeruli, are completely removed.
The potential significance of these interstitial and tubular
findings derives from the strong relationship between the
severity of tubular and interstitial injury and clinical
progression of established renal disease,1–4 including D
nephropathy.17,18 It was a major concern, therefore, that the
interstitial fibrosis, already present in all pts before
transplantation, and thus consequent to diabetes,15,18 had
worsened at 5 years after PTA, despite cure of the D state.
This worsening was probably due to the administration of
CSA following PTA, since the severity of interstitial expan-
sion between the baseline and the 5 years biopsy was highly
correlated with the dose and blood levels of CSA during the
first year after PTA.19 There was also an increase in Vv(AT/
TT) and the percentage of globally sclerotic glomeruli
between the baseline and 5-year biopsies.19
Reductions in CSA dose over time or prolonged
normoglycemia or both could have contributed to the
findings of interstitial structural improvement in our studies.
Our study design, however, did not allow dissection between
these or other possible hypotheses. For example, we
documented a reduction at 5 and 10 years in AER in the
PTA recipients with elevated baseline AER values, and
proteinuria and tubulointerstitial injury have been patho-
genetically linked.24–26 The changes in AER in our study
tended to correlate with the changes in interstitial and
tubular parameters. Thus, given the small number of pts, the
lack of statistically significant correlations between the
magnitude of AER reduction and the changes in structural
parameters from the fifth to the 10th year does not rule out
this possibility.
Nonetheless, whatever the mechanisms, these studies
document the potential for reversal of interstitial fibrosis in
humans. This is most unlikely to occur spontaneously, as in a
group of pts with persistent type I diabetes Vv(Int/cortex)
and Vv(AT/TT), increased at first observation, did not change
over 5 years of follow-up.19
The percent of glomeruli that were globally sclerotic did
not change between the fifth and the 10th year. This is
consistent with the sclerotic glomeruli not being reabsorbed,
taking longer to be removed than their associated AT, or
continuing to develop at about the same rate as they are
removed. We favor the second hypothesis since some sclerotic
glomeruli appeared be losing PAS-positive basement mem-
brane material (Figure 2c). However, given the continuous
gradation of staining of sclerotic glomeruli, this was not
quantifiable. Moreover, many sclerotic glomeruli had lost at
least part of Bowman’s capsule. This Bowman’s capsular loss
promoted direct access of interstitial cells to glomerular tuft
material, likely facilitating glomerular reabsorption.
Arteriolar hyalinosis lesions, common to both D nephro-
pathy27 and CSA nephrotoxicity,20,28 did not change between
the fifth and 10th post-PTA years. Thus, once established,
these lesions may not be reversible and, previously linked to
glomerular sclerosis,27 may be important in clinical progres-
sion of both disorders.
In conclusion, whether secondary to long-term normo-
glycemia, reduction in CSA dose, or other factors, this study
demonstrates that the human kidney has the mechanisms
necessary to heal interstitial fibrosis, remove AT, and undergo
architectural remodeling towards normal. Given the impor-
tance of tubular and interstitial lesions to the progression of
chronic renal diseases,1–4,18 understanding of the cellular
regulation of these healing phenomena could lead to new
therapeutic approaches.
MATERIALS AND METHODS
Pts and study design
Type I D pts who were recipients of successful PTA and were insulin
independent and euglycemic for 10 years after PTA were eligible for
this study. These pts, in addition, had to have a kidney biopsy
performed before and 5 and 10 years after PTA.13 Of the original
cohort of 13 pts studied at 5 years after PTA,21 two developed end-
stage renal disease between the fifth and 10th post-PTA years; these
two pts had the most advanced renal structural changes and renal
dysfunction at the time of PTA. Eight pts meeting these criteria were
included. Four had received a cadaveric pancreas and four a
segmental pancreas graft from living related donors. After induction
therapy, all pts received immunosuppression with prednisone,
azathioprine, and cyclosporine (CSA) throughout the 10 years of
the study. These studies were approved by the Committee for the
Use of Human Subjects in Research of the University of Minnesota.
All pts gave written informed consent before each evaluation.
Measures of renal function, metabolic parameters, and percutaneous
renal biopsy were obtained before and 5 and 10 years after PTA. The
results of the baseline, 5 and 10 years follow-up clinical data, and of
D glomerulopathy and TBM lesions have been reported pre-
viously.13 Briefly, pts (2M/6F) were 3373 years old, with D duration
of 2275 years at the time of PTA. Glycosylated hemoglobin was
normal at 5 and 10 years (5.370.4 and 5.570.7%, respectively).
Fasting blood glucose levels were 89.974.45 and 95.979.2 mg/dl at
5 and 10 years, respectively; fasting insulin levels were 23.3719.9
and 19.976.8mU/ml at 5 and 10 years. Fasting plasma C-peptide
data in insulin-independent long-term successful pancreas trans-
plant recipients at our institution are 3.4770.36 (mean7s.e.) in
recipients of whole pancreas and 1.9570.37 ng/ml in segmental
graft recipients, and 1.2570.11 in normal controls, as reported
previously.29 Creatinine clearance decreased from 108720 to
65712 ml/min/1.73 m2 at 1 year post-PTA (Po0.001) and did not
change significantly thereafter (74716 and 74714 ml/min/1.73 m2
at 5 and 10 years, respectively).13 AER was 103 (7–1276) mg/24 h
before PTA and did not significantly change at 5 years (30
(2–155) mg/24 h, P¼ 0.07 vs baseline) and 10 years (20
(6–176) mg/24 h, NS vs baseline and 5 years) although there was a
trend towards reduction. AER was significantly reduced when only
recipients with elevated baseline AER values were considered.13 The
mean blood pressure also did not statistically significantly change
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(8875, 9278 and 97712 mmHg at baseline, 5, and 10 years,
respectively); however, the number of pts receiving antihypertensive
therapy increased from 2 before PTA to 5 at 5 and 10 years. No pt
received angiotensin-converting enzyme inhibitor or lipid-lowering
agents during the study.13
Here we focus on the 5- and 10-year results related to structural
studies of the renal interstitium, tubules, and arterioles.
Procedures
All pts spent 1 week in the General Clinical Research Center at the
University of Minnesota for pre-PTA evaluation and several days for
each follow-up evaluation. During each hospitalization, pts under-
went multiple 24-h urine collections (at least three) for measure-
ments of creatinine clearance by the Jaffe´ reaction (normal range:
90-130 ml/min/1.73 m2) and urinary AER by nephelometry (normal
values: o22 mg/24 h). Blood pressure was measured repeatedly by
the General Clinical Research Center nursing staff. Glycosylated
hemoglobin was measured by high-performance liquid chromato-
graphy (BioRad Diamat, BioRad Laboratories, Hercules, CA, USA)
(normal range: 4.0–6.1%), and insulin levels by radioimmunoassay.
CSA blood levels were measured by high-performance liquid
chromatography on blood samples drawn 12 h after CSA adminis-
tration.
Renal biopsy studies
Light microscopy. Tissue for light microscopy was fixed in
Zenker’s solution, embedded in paraffin, cut in 2–3 mm sections, and
stained with PAS stain. All morphometric measurements and
semiquantitative estimates were blindly performed.
Vv(Int/cortex), the fraction of the renal cortex which is
interstitium, was estimated using a projection microscope at
 300, as described previously.19 All available cortical tissue was
measured. Points falling on the interstitium, defined as the space
outside Bowman’s capsule, TBM, and vessels larger than one tubular
diameter, and total number of points overlying the cortical tissue
were counted using a 1:4 grid with a distance between fine points of
13 mm (normal value: 0.1570.02).
Percent sclerosed glomeruli was determined when at least 20
glomeruli were available for study27 (normal value: o10%). All but
two of the 24 biopsies examined were adequate for this measure-
ment. In order to explore whether the sclerosed glomeruli could be
undergoing reabsorption, a semiquantitative estimate of the
percentage of the profile of each sclerosed glomerulus surrounded
by intact Bowman’s capsule was performed.
Tubular atrophy was defined by the presence of thickened or
reduplicated TBM surrounding tubules of reduced diameters,
containing shortened or flat tubular epithelial cells; in the absence
of thickened TBM, atrophy was defined as a tubular diameter
reduced to less than 50% of normal, as determined by comparison
with profiles of adjacent tubules surrounded by TBM and with the
presence of luminal space in the tubular profile.28 Fractional volume
of AT, the proportion of the volume of total cortical tubules (TT)
composed of AT (Vv(AT/TT)), was estimated by point counting
using a projection microscope at  300. All available cortical tissue
was measured. A 1:9 grid with a distance between fine points of
10 mm was used. Points falling on AT were divided by the total
number of points falling on all cortical tubules.
The average tubular profile area of non-AT was estimated on
sections with adequate cortical tissue on the 5- and 10-year post-
PTA biopsies. Sections were viewed using a projection microscope at
 300. A staggered cycloid grid with cycloid length per point (l/
p)¼ 100mm and area per point (a/p)¼ 714 mm2 was superimposed
on the projected images. The short axes of cycloids were aligned
parallel to the long axes of tissue sections (vertical axes). Three to six
adjacent non-overlapping fields per slide were studied per biopsy,
yielding a minimum number of 150 points hitting proximal tubular
(PT) profiles and of 150 intercepts between the cycloids and TBM.
The surface density of PT per cortex was estimated as described
elsewhere.30
The volume density of PT per cortex (Vv(PT/cortex)) was
estimated by point counting. The average proximal TPA was
estimated using the following equation:31
TPA ¼ 4pV
2
V ðPT=cortexÞ
S2V ðPT=cortexÞ
The same method was used to determine the average distal tubular
profile area.
The possibility that partial or complete reabsorption of AT could
occur was evaluated as follows. Since sclerosed glomeruli are
typically associated with adjacent AT, light microscopic slides were
blindly evaluated for the presence of sclerotic glomeruli, which were
not accompanied by AT within a distance of one normal tubular
diameter from the scarred glomerulus. This analysis was performed
on one slide only (serial sections were not available on all biopsies),
and therefore we cannot exclude the possibility that residual AT were
present adjacent to the sclerotic glomerlus in another section plane.
The index of arteriolar hyalinosis was obtained by subjective
estimation of the fraction of each arteriolar wall replaced by hyaline
material in one complete light microscopy section, as described
previously.32 Then, the following formula was applied:
Numerator : 1n of arterioles with a score 0:25
2n of arterioles with a score 0:25  0:50
2n of arterioles with a score 0:51  0:75
4n of arterioles with a score 0:76
Denominator: Total number of arterioles counted.
A mean of 32 arterioles (range: 9–110) were evaluated per biopsy.
Electron microscopy. Interstitial composition was evaluated on
the 5 and 10 years post-PTA biopsies using stereological methods on
images obtained at  7500 by systematic unbiased sampling
through predetermined movements of the EM stage controls, as
described previously.23 During acquisition of the micrographs, areas
containing a part of a glomerulus or vessels larger than a tubule
diameter were excluded. Thus, sampling was preferentially one
tubular diameter or more from these structures. This largely avoided
the potential bias of sampling of peri-glomerular fibrosis or vascular
adventitia. Two EM blocks per biopsy were studied, with the
acquisition of 62718 micrographs per biopsy. The cortical
interstitium was divided into four components: cells (Cell), collagen
(Coll), capillaries (Cap), and ‘undefined space’ (Space). The volume
fraction of the cortical interstitium occupied by each interstitial
component, Vv(Cell/int), Vv(Coll/int), Vv(Cap/int), and Vv(Space/
int) was estimated by point counting.23 Volume fractions of these
interstitial components were measured using a 1:9 lattice grid with a
distance between fine points of 20 mm. Coarse points were used to
quantitate the interstitium, while fine points were counted on each
of the four interstitial components. The mean number of coarse and
fine points counted per biopsy was 5357108 and 19417398,
respectively. The volume fraction of the cortical interstitium
occupied by each component was calculated as Vv(Compx/
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Int)¼ FPx/(CP 9). The volume fraction of the cortical tissue
occupied by each interstitial component was obtained by multi-
plying the volume fraction of each compound with Vv(Int/cortex).
Statistics
Results are expressed as mean71s.d., except for AER which, not
normally distributed, is expressed as the median and range. AER
values were logarithmically transformed before analyses. Compar-
isons of 5- and 10-years follow-up data used the paired two-sided
Student’s t-test. Linear regression analyses were used to evaluate the
relationships between CSA dose and plasma levels, and between
changes in AER and in structural parameters. The binomial test was
used to compare the observed frequencies of biopsies with and
without sclerotic glomeruli, which were unaccompanied by AT.
Where there was a 0 in one of these categories, a probability value of
1% was assigned to that category and 99% to the other. Statistical
significance was set at Po0.05; however, all P-values o0.10 are
provided.
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